IP Library Granted Patent US 8,348,896
Granted Patent B2
US 8,348,896 · App. 12/742,938 · Granted Jan 8, 2013

Patency check with pressure monitoring

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,348,896
App. No.
12/742,938
Granted
Jan 8, 2013
Kind
B2
Abstract

A patency check protocol ( 150 ) for evaluating a patency check injection ( 156 ) is disclosed. The protocol ( 150 ) incorporates a pressure standard ( 152 ) (e.g., a pressure threshold; a target pressure curve). A pressure associated with the patency check injection is monitored ( 160 ) and compared against this pressure standard ( 164 ). If a first condition is identified ( 166 ) (e.g., if the pressure threshold is reached; if the monitored pressure deviates from the target pressure curve by more than a certain predetermined amount), one or more actions may be undertaken ( 168 ) (e.g., one or more notifications or alerts may be issued; the flow rate may be reduced for the patency check injection; the patency check injection may be suspended/terminated).

Claims (38)

1. A power injector, comprising:

a powerhead;

a syringe plunger drive assembly;

patency check logic configured to execute a patency check injection to assess for both blockage in a flowpath to a patient's vein and existence of an extravasation condition where fluid is being introduced into a patient's tissue instead of a vein, wherein said patency check logic comprises a pressure standard;

pressure monitoring logic, wherein an output from said pressure monitoring logic is provided to said patency check logic for comparison with said pressure standard, wherein said patency check logic is configured to identify an existence of a first condition, wherein said first condition is either when a monitored pressure during a patency check injection reaches or exceeds a pressure threshold, or when a monitored pressure during a patency check injection deviates from a target pressure curve by more than a certain amount; and

injection protocol logic, separate from said patency check logic, configured to execute an injection protocol after said patency check logic executes a patency check injection, wherein said injection protocol logic comprises a comparator, wherein a first input to said comparator comprises a pressure from a patency check injection when said patency check logic failed to identify an occurrence of said first condition, and wherein a second input to said comparator comprises a monitored pressure during a subsequent execution of an injection protocol.

2. The power injector of claim 1 , further comprising a syringe mounted on said powerhead, wherein said syringe comprises a syringe barrel and a plunger movably disposed within said syringe barrel, and wherein said syringe plunger drive assembly may interact with said plunger to move said plunger.

3. The power injector of claim 1 , wherein said first input for said comparator is one of a maximum pressure encountered during a patency check injection and an average pressure encountered during a patency check injection.

4. The power injector of claim 1 , wherein said pressure monitoring logic is configured to monitor a back-pressure during a patency check injection.

5. The power injector of claim 1 , wherein said pressure standard comprises said pressure threshold.

6. The power injector of claim 1 , wherein said pressure standard comprises said target pressure curve.

7. The power injector of claim 1 , further comprising at least one data entry device operatively interconnected with said patency check logic, wherein said pressure standard may be input using said at least one data entry device.

8. The power injector of claim 7 , wherein said at least one data entry device is selected from the group consisting of a touch screen display, a soft key display, a keyboard, a mouse, touch pad, and a track ball.

9. The power injector of claim 1 , further comprising a display, wherein said patency check logic is configured to present on said display a representation of a monitored pressure from a patency check injection.

10. The power injector of claim 9 , wherein said representation of a monitored pressure is selected from the group consisting of a numeric representation of a pressure value, a graphical representation of a pressure value, or a combination thereof.

11. The power injector of claim 9 , wherein said patency check logic is configured to present said representation of a monitored pressure on said display on a real-time basis.

12. The power injector of claim 9 , wherein said patency check logic is configured to present said representation of a monitored pressure on said display after completion of a patency check injection.

13. The power injector of claim 1 , wherein said patency check logic is configured to provide at least one notification when said patency check logic identifies an occurrence of said first condition.

14. The power injector of claim 13 , wherein said at least one notification is selected from the group consisting of a textual message, an alphanumeric message, at least one visual alarm, at least one audible alarm, or any combination thereof.

15. The power injector of claim 1 , wherein said patency check logic is configured to terminate a patency check injection if said patency check logic identifies an occurrence of said first condition.

16. The power injector of claim 1 , wherein user input is required if said patency check logic identifies an occurrence of said first condition.

17. The power injector of claim 1 , wherein said patency check logic is configured to reduce a flow rate for a patency check injection if said patency check logic identifies an occurrence of said first condition.

18. The power injector of claim 1 , wherein said patency check logic is configured to initiate a first action if there is a first relationship between said pressure standard and a monitored pressure from a patency check injection, wherein said first action is selected from the group consisting of suspending the patency check injection, terminating the patency check injection, reducing a flow rate for the patency check injection, providing at least one notification, or any combination thereof.

19. The power injector of claim 1 , wherein said patency check logic is configured to display a message upon completion of a patency check injection procedure.

20. The power injector of claim 19 , wherein said injection protocol logic is operatively interconnected with said patency check logic, and wherein user input is required after execution of a patency check injection using said patency check logic and prior to executing an injection protocol using said injection protocol logic.

21. A method for executing a first medical procedure, comprising the steps of:

fluidly interconnecting a patient with a power injector;

injecting a first fluid into said patient using said power injector, wherein said first fluid is an initial fluid injected into said patient by said power injector for said first medical procedure;

monitoring said injecting a first fluid step for an occurrence of a first condition, wherein said first condition is either when a pressure during said injecting a first fluid step reaches or exceeds a pressure threshold, or when a pressure during said injecting a first fluid step deviates from a target pressure curve by more than a certain amount;

assessing for both blockage in a flowpath to said patient and existence of an extravasation condition where fluid is being introduced into said patient's tissue instead of a vein, said assessing step comprising comparing an output of said monitoring step for said first fluid with a first standard, wherein said comparing step is executed by power injector control logic;

injecting a second fluid into said patient using said power injector, wherein said injecting a second fluid step is executed after said injecting a first fluid step; and

monitoring said injecting a second fluid step, comprising comparing a pressure from said injecting a second fluid step with a pressure from said injecting a first fluid step when said monitoring step for said first fluid failed to identify an occurrence of said first condition.

22. A power injector, comprising:

a powerhead;

a syringe plunger drive assembly;

patency check logic configured to execute a patency check injection to assess for both blockage in a flowpath to a patient's vein and existence of an extravasation condition where fluid is being introduced into a patient's tissue instead of a vein, wherein said patency check logic comprises a pressure standard;

injection protocol logic, separate from said patency check logic, configured to execute an injection protocol after said patency check logic executes a patency check injection; and

pressure monitoring logic, wherein an output from said pressure monitoring logic is used by both said patency check logic and said injection protocol logic.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2010
From: WAGNER, GARY S.
To: MALLINCKRODT INC.
Reel/Frame 024386/0531 →